Search Within

Andrew D Seidman

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (13)
Groups
  1. Breast Medicine Service (28)
  2. Department of Medicine (28)
  3. Department of Pathology and Laboratory Medicine (28)
  4. Solid Tumor Oncology Division (28)
  5. Biostatistics Service (19)
  6. Epidemiology and Biostatistics (19)

More Groups

People
  1. Edi Brogi (16)
  2. Larry Norton (12)
  3. Clifford Hudis (11)
  4. Lee Tan (10)
  5. Shanu Modi (10)
  6. Katherine Panageas (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (2)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Breast Cancer Research and Treatment (5)
  3. npj Breast Cancer (4)
  4. Annals of Oncology (2)
  5. Laboratory Investigation (2)
  6. Cancer Investigation (1)

More Publications

Publishers
  1. Springer (7)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (6)
  4. American Association for Cancer Research (2)
  5. Elsevier Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
    Journal Article

    Modi, S.; Seidman, A. D.; Dickler, M.; Moasser, M.; D'Andrea, G.; Moynahan, M. E.; Menell, J.; Panageas, K. S.; Tan, L. K.; Norton, L.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer
    Journal Article

    Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; more...
    Cancer Investigation (2005)

    Fulltext@MSK | Save
  • Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC)
    Meeting Abstract

    Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer
    Journal Article

    Van Poznak, C.; Tan, L.; Panageas, K. S.; Arroyo, C. D.; Hudis, C.; Norton, L.; Seidman, A. D.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for Her2/neu in metastatic breast cancer (BC)
    Meeting Abstract

    Kaptain, S.; Seidman, A. D.; Esteva, F. J.; Fornier, M.; Arroyo, C.; Chin, J.; Willey, J.; Reuter, V.; Hudis, C.; Norton, L.; more...
    Laboratory Investigation (2000)

    Fulltext@MSK | Save
  • Weekly (W) herceptin (H) and taxol (T) for metastatic breast cancer (MBC): Correlation of response rate to HER2 immunophenotype (immunohistochemistry (IHC)) and gene amplification (fluorescent in-situ hybridization (FISH))
    Meeting Abstract

    Fornier, M.; Seidman, A. D.; Esteva, F.; Tan, L.; Kaptain, S.; Bach, A.; Arroyo, C. D.; Hortobagyi, G.; Norton, L.; Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Clinical-pathologic assessment of the clinical sensitivity to single agent taxane (T) therapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Van Poznak, C.; Tan, L.; Panageas, K.; Arroyo, C.; Hudis, C.; Norton, L.; Seidman, A. D.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save